Glen Santangelo
Stock Analyst at Jefferies
(2.63)
# 2,240
Out of 5,072 analysts
78
Total ratings
52%
Success rate
2.56%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $130 → $134 | $105.18 | +27.40% | 6 | Sep 3, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $7.59 | +5.40% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $84.79 | -5.65% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $10.69 | +21.61% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $36.91 | +38.17% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $7.18 | -16.43% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.90 | +5.26% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $11.34 | +76.37% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $23.68 | -23.99% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $26.37 | -8.99% | 4 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $23 | $39.76 | -42.15% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $26.89 | -14.47% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $46.68 | -5.74% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $23.27 | -26.94% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $128.18 | +79.44% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $9.10 | +998.90% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $27.72 | +152.53% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $43.00 | +27.91% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $15.62 | +2.43% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $51.44 | -10.58% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.99 | +836.45% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $20.49 | +241.63% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $4.23 | +2,736.88% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $3.38 | -40.74% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.81 | +1,572.60% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.84 | +1,169.84% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $80.36 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $881.12 | -80.82% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $212.26 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $74.57 | +9.96% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $147.19 | +69.85% | 1 | Dec 8, 2017 |
HealthEquity
Sep 3, 2025
Maintains: Buy
Price Target: $130 → $134
Current: $105.18
Upside: +27.40%
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $7.59
Upside: +5.40%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $84.79
Upside: -5.65%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $10.69
Upside: +21.61%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $36.91
Upside: +38.17%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $7.18
Upside: -16.43%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.90
Upside: +5.26%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $11.34
Upside: +76.37%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $23.68
Upside: -23.99%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $26.37
Upside: -8.99%
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $39.76
Upside: -42.15%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $26.89
Upside: -14.47%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $46.68
Upside: -5.74%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $23.27
Upside: -26.94%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $128.18
Upside: +79.44%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $9.10
Upside: +998.90%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $27.72
Upside: +152.53%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $43.00
Upside: +27.91%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $15.62
Upside: +2.43%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $51.44
Upside: -10.58%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.99
Upside: +836.45%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $20.49
Upside: +241.63%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $4.23
Upside: +2,736.88%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $3.38
Upside: -40.74%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $2.81
Upside: +1,572.60%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.84
Upside: +1,169.84%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $80.36
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $881.12
Upside: -80.82%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $212.26
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $74.57
Upside: +9.96%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $147.19
Upside: +69.85%